Leptin in Health and Disease: Facts and Expectations at its Twentieth Anniversary

Metabolism: Clinical and Experimental

Volumn 64, Issue 1, 2015, Pages 5-12

  Polyzos, Stergios A ^a   Mantzoros, Christos S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; METRELEPTIN;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FAT MASS; FATTY LIVER; FOOD INTAKE; HUMAN; HYPERLEPTINEMIA; INTRACELLULAR SIGNALING; LEPTIN DEFICIENCY; LIPODYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; CLINICAL TRIAL (TOPIC);

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; LEPTIN;

EID: 84923636274     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.017     Document Type: Editorial

References (95)

1. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
2. T. Kelesidis, I. Kelesidis, S. Chou, and C.S. Mantzoros Narrative review: the role of leptin in human physiology: emerging clinical applications Ann Intern Med 152 2010 93 100
3. G.R. Hervey The effects of lesions in the hypothalamus in parabiotic rats J Physiol 145 1959 336 352
4. D.L. Coleman Effects of parabiosis of obese with diabetes and normal mice Diabetologia 9 1973 294 298
5. S. Lehr, S. Hartwig, D. Lamers, S. Famulla, S. Muller, and F.G. Hanisch Identification and validation of novel adipokines released from primary human adipocytes Mol Cell Proteomics 11 2012 M111.010504; http://dx.doi.org/10.1074/mcp.M111.010504
6. C.S. Mantzoros, S. Moschos, I. Avramopoulos, V. Kaklamani, A. Liolios, and D.E. Doulgerakis Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans J Clin Endocrinol Metab 82 1997 3408 3413
7. B.E. Wolfe, D.C. Jimerson, C. Orlova, and C.S. Mantzoros Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers Clin Endocrinol (Oxf) 61 2004 332 338
8. S.A. Shea, M.F. Hilton, C. Orlova, R.T. Ayers, and C.S. Mantzoros Independent circadian and sleep/wake regulation of adipokines and glucose in humans J Clin Endocrinol Metab 90 2005 2537 2544
9. L.A. Tartaglia, M. Dembski, X. Weng, N. Deng, J. Culpepper, and R. Devos Identification and expression cloning of a leptin receptor, OB-R Cell 83 1995 1263 1271
10. M. Dalamaga, S.H. Chou, K. Shields, P. Papageorgiou, S.A. Polyzos, and C.S. Mantzoros Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives Cell Metab 18 2013 29 42
11. H.S. Moon, M. Dalamaga, S.Y. Kim, S.A. Polyzos, O.P. Hamnvik, and F. Magkos Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals Endocr Rev 34 2013 377 412
12. R.S. Ahima, D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, and E. Maratos-Flier Role of leptin in the neuroendocrine response to fasting Nature 382 1996 250 252
13. C.S. Mantzoros, F. Magkos, M. Brinkoetter, E. Sienkiewicz, T.A. Dardeno, and S.Y. Kim Leptin in human physiology and pathophysiology Am J Physiol Endocrinol Metab 301 2011 E567 E584
14. S. Bluher, S. Shah, and C.S. Mantzoros Leptin deficiency: clinical implications and opportunities for therapeutic interventions J Investig Med 57 2009 784 788
15. C.G. Fiorenza, S.H. Chou, and C.S. Mantzoros Lipodystrophy: pathophysiology and advances in treatment Nat Rev Endocrinol 7 2011 137 150
16. J.P. Foo, and C.S. Mantzoros Leptin in congenital or HIV-associated lipodystrophy and metabolic syndrome: a need for more mechanistic studies and large, randomized, placebo-controlled trials Metabolism 61 2012 1331 1336
17. M.A. Tsoukas, O.M. Farr, and C.S. Mantzoros Leptin in congenital and HIV-associated lipodystrophy Metabolism 2014 10.1016/j.metabol.2014.07.017 [in press]
18. J.L. Chan, K. Lutz, E. Cochran, W. Huang, Y. Peters, and C. Weyer Clinical effects of long-term metreleptin treatment in patients with lipodystrophy Endocr Pract 17 2011 922 932
19. E.A. Oral, V. Simha, E. Ruiz, A. Andewelt, A. Premkumar, and P. Snell Leptin-replacement therapy for lipodystrophy N Engl J Med 346 2002 570 578
20. K. Ebihara, T. Kusakabe, M. Hirata, H. Masuzaki, F. Miyanaga, and N. Kobayashi Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy J Clin Endocrinol Metab 92 2007 532 541
21. S.B. Heymsfield, A.S. Greenberg, K. Fujioka, R.M. Dixon, R. Kushner, and T. Hunt Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial JAMA 282 1999 1568 1575
22. G.K. Shetty, G. Matarese, F. Magkos, H.S. Moon, X. Liu, and A.M. Brennan Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet Eur J Endocrinol 165 2011 249 254
23. C.S. Mantzoros, and J.S. Flier Editorial: leptin as a therapeutic agent - trials and tribulations J Clin Endocrinol Metab 85 2000 4000 4002
24. H. Hsuchou, A.J. Kastin, H. Tu, N. Joan Abbott, P.O. Couraud, and W. Pan Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells J Neurochem 115 2010 1288 1298
25. H. Hsuchou, P.K. Mishra, A.J. Kastin, X. Wu, Y. Wang, and S. Ouyang Saturable leptin transport across the BBB persists in EAE mice J Mol Neurosci 51 2013 364 370
26. B. Burguera, M.E. Couce, G.L. Curran, M.D. Jensen, R.V. Lloyd, and M.P. Cleary Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats Diabetes 49 2000 1219 1223
27. H. Nave, S. Kuhlmann, G. Brabant, and R. Pabst Changes in cerebral endothelial barrier antigen, without alteration of permeability for intravenously injected leptin in diet-induced obesity in rats Exp Toxicol Pathol 55 2003 45 49
28. N. Nonaka, S.M. Hileman, S. Shioda, T.Q. Vo, and W.A. Banks Effects of lipopolysaccharide on leptin transport across the blood-brain barrier Brain Res 1016 2004 58 65
29. W. Pan, M. Barron, H. Hsuchou, H. Tu, and A.J. Kastin Increased leptin permeation across the blood-brain barrier after chronic alcohol ingestion Neuropsychopharmacology 33 2008 859 866
30. V. Cano, B. Merino, L. Ezquerra, B. Somoza, and M. Ruiz-Gayo A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin Br J Pharmacol 154 2008 1009 1015
31. G. Wiesner, M. Vaz, G. Collier, D. Seals, D. Kaye, and G. Jennings Leptin is released from the human brain: influence of adiposity and gender J Clin Endocrinol Metab 84 1999 2270 2274
32. M. Morroni, R. De Matteis, C. Palumbo, M. Ferretti, I. Villa, and A. Rubinacci In vivo leptin expression in cartilage and bone cells of growing rats and adult humans J Anat 205 2004 291 296
33. K. Lee, M. Santibanez-Koref, T. Polvikoski, D. Birchall, A.D. Mendelow, and B. Keavney Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture Atherosclerosis 226 2013 74 81
34. Y.L. Fan, and X.Q. Li Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes Clin Endocrinol (Oxf) 2014 10.1111/cen.12598
35. S.M. Smith-Kirwin, D.M. O'Connor, J. De Johnston, E.D. Lancey, S.G. Hassink, and V.L. Funanage Leptin expression in human mammary epithelial cells and breast milk J Clin Endocrinol Metab 83 1998 1810 1813
36. R. Iciek, E. Wender-Ozegowska, A. Zawiejska, P. Mikolajczak, P.M. Mrozikiewicz, and M. Pietryga Placental leptin and its receptor genes expression in pregnancies complicated by type 1 diabetes J Physiol Pharmacol 64 2013 579 585
37. J. Martin-Gonzalez, A. Perez-Perez, F. Sanchez-Jimenez, A. Carmona-Fernandez, D. Torres-Lagares, and V. Sanchez-Margalet Leptin receptor is up-regulated in inflamed human dental pulp J Endod 39 2013 1567 1571
38. C.S. Mantzoros, A. Varvarigou, V.G. Kaklamani, N.G. Beratis, and J.S. Flier Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns J Clin Endocrinol Metab 82 1997 2856 2861
39. B.N. Finck, and R.W. Johnson Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha Am J Physiol Regul Integr Comp Physiol 282 2002 R1429 R1435
40. L. Gan, K. Guo, M.L. Cremona, T.E. McGraw, R.L. Leibel, and Y. Zhang TNF-alpha up-regulates protein level and cell surface expression of the leptin receptor by stimulating its export via a PKC-dependent mechanism Endocrinology 153 2012 5821 5833
41. S.M. Lee, H.J. Choi, C.H. Oh, J.W. Oh, and J.S. Han Leptin increases TNF-alpha expression and production through phospholipase D1 in Raw 264.7 cells PLoS One 9 2014 e102373 10.1371/journal.pone.0102373
42. H. Tilg, and G.S. Hotamisligil Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance Gastroenterology 131 2006 934 945
43. S.A. Polyzos, J. Kountouras, and C. Zavos The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease Hippokratia 13 2009 127
44. J.A. Handy, P.P. Fu, P. Kumar, J.E. Mells, S. Sharma, and N.K. Saxena Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis Biochem J 440 2011 385 395
45. I.L. Beales, C. Garcia-Morales, O.O. Ogunwobi, and G. Mutungi Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B Mol Cell Endocrinol 382 2014 150 158
46. C. Gutierrez-Repiso, S. Garcia-Serrano, F. Rodriguez-Pacheco, E. Garcia-Escobar, J.J. Haro-Mora, and J. Garcia-Arnes FNDC5 could be regulated by leptin in adipose tissue Eur J Clin Invest 2014 10.1111/eci.12324
47. A. Rodriguez, S. Becerril, L. Mendez-Gimenez, B. Ramirez, N. Sainz, and V. Catalan Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice Int J Obes (Lond) 2014 10.1038/ijo.2014.166
48. S.A. Polyzos, J. Kountouras, A.D. Anastasilakis, E.V. Geladari, and C.S. Mantzoros Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2014 207 217
49. S.A. Polyzos, J. Kountouras, C. Zavos, and G. Deretzi The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of literature J Clin Gastroenterol 45 2011 50 54
50. H.S. Moon, J.Y. Huh, F. Dincer, B.E. Schneider, P.O. Hasselgren, and C.S. Mantzoros Identification, and saturable nature, of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo and in vitro administration Diabetes 2014 10.2337/db14-0625
51. C.S. Mantzoros, A.D. Liolios, N.A. Tritos, V.G. Kaklamani, D.E. Doulgerakis, and I. Griveas Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men Obes Res 6 1998 179 186
52. C. Duan, M. Li, and L. Rui SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin J Biol Chem 279 2004 43684 43691
53. D. Ren, M. Li, C. Duan, and L. Rui Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice Cell Metab 2 2005 95 104
54. L. Sheng, Y. Liu, L. Jiang, Z. Chen, Y. Zhou, and K.W. Cho Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice PLoS One 8 2013 e83269 10.1371/journal.pone.0083269
55. B. Emanuelli, P. Peraldi, C. Filloux, D. Sawka-Verhelle, D. Hilton, and O.E. Van SOCS-3 is an insulin-induced negative regulator of insulin signaling J Biol Chem 275 2000 15985 15991
56. M.G. Myers, M.A. Cowley, and H. Munzberg Mechanisms of leptin action and leptin resistance Annu Rev Physiol 70 2008 537 556
57. K. Ueki, T. Kondo, and C.R. Kahn Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms Mol Cell Biol 24 2004 5434 5446
58. P. Kievit, J.K. Howard, M.K. Badman, N. Balthasar, R. Coppari, and H. Mori Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells Cell Metab 4 2006 123 132
59. E. Burgos-Ramos, L. Sackmann-Sala, E. Baquedano, D. Cruz-Topete, V. Barrios, and J. Argente Central leptin and insulin administration modulates serum cytokine- and lipoprotein-related markers Metabolism 61 2012 1646 1657
60. J.W. Hill, C.F. Elias, M. Fukuda, K.W. Williams, E.D. Berglund, and W.L. Holland Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility Cell Metab 11 2010 286 297
61. F. Magkos, A. Brennan, L. Sweeney, E.S. Kang, J. Doweiko, and A.W. Karchmer Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study Metabolism 60 2011 1045 1049
62. S.A. Polyzos, J. Kountouras, and C. Zavos Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines Curr Mol Med 72 2009 299 314
63. D. Cai Neuroinflammation and neurodegeneration in overnutrition-induced diseases Trends Endocrinol Metab 24 2013 40 47
64. J.P. Thaler, C.X. Yi, E.A. Schur, S.J. Guyenet, B.H. Hwang, and M.O. Dietrich Obesity is associated with hypothalamic injury in rodents and humans J Clin Invest 122 2012 153 162
65. I. Gabriely, X.H. Ma, X.M. Yang, L. Rossetti, and N. Barzilai Leptin resistance during aging is independent of fat mass Diabetes 51 2002 1016 1021
66. O.M. Farr, M.A. Tsoukas, and C.S. Mantzoros Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders Metabolism 2014 10.1016/j.metabol.2014.07.004
67. S. Fulton, B. Woodside, and P. Shizgal Modulation of brain reward circuitry by leptin Science 287 2000 125 128
68. D.V. Khanh, Y.H. Choi, S.H. Moh, A.W. Kinyua, and K.W. Kim Leptin and insulin signaling in dopaminergic neurons: relationship between energy balance and reward system Front Psychol 5 2014 846 10.3389/fpsyg.2014.00846
69. A.M. Jastreboff, C. Lacadie, D. Seo, J. Kubat, M.A. Van Name, and C. Giannini Leptin is associated with exaggerated brain reward and emotion responses to food images in adolescent obesity Diabetes Care 2014 10.2337/dc14-0525
70. J.J. Macleod Insulin and diabetes: a general statement of the physiological and therapeutic effects of insulin Br Med J 2 1922 833 835
71. S. Tsiodras, A. Perelas, C. Wanke, and C.S. Mantzoros The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications J Infect 61 2010 101 113
72. F. Magkos, and C.S. Mantzoros Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment Metabolism 60 2011 749 753
73. J.H. Lee, J.L. Chan, E. Sourlas, V. Raptopoulos, and C.S. Mantzoros Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy J Clin Endocrinol Metab 91 2006 2605 2611
74. M.K. Leow, C.L. Addy, and C.S. Mantzoros Clinical review 159: Human immunodeficiency virus/highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies J Clin Endocrinol Metab 88 2003 1961 1976
75. S.H. Chou, J.P. Chamberland, X. Liu, G. Matarese, C. Gao, and R. Stefanakis Leptin is an effective treatment for hypothalamic amenorrhea Proc Natl Acad Sci U S A 108 2011 6585 6590
76. J.P. Foo, S.A. Polyzos, A.D. Anastasilakis, S. Chou, and C.S. Mantzoros The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis and Wnt inhibitors in young women with hypothalamic amenorrhea J Clin Endocrinol Metab 2014 10.1210/jc.2014-2491:jc20142491
77. C.K. Welt, J.L. Chan, J. Bullen, R. Murphy, P. Smith, and A.M. DePaoli Recombinant human leptin in women with hypothalamic amenorrhea N Engl J Med 351 2004 987 997
78. E. Sienkiewicz, F. Magkos, K.N. Aronis, M. Brinkoetter, J.P. Chamberland, and S. Chou Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women Metabolism 60 2011 1211 1221
79. J.L. Chan, and C.S. Mantzoros Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa Lancet 366 2005 74 85
80. G. Paz-Filho, C.A. Mastronardi, and J. Licinio Leptin treatment: facts and expectations Metabolism 2014 10.1016/j.metabol.2014.07.014
81. M. Iwanishi, K. Ebihara, T. Kusakabe, M. Washiyama, J. Ito-Kobayashi, and F. Nakamura Primary intestinal follicular lymphoma and premature atherosclerosis in a Japanese diabetic patient with atypical familial partial lipodystrophy Intern Med 53 2014 851 858
82. K. Imajo, K. Fujita, M. Yoneda, Y. Nozaki, Y. Ogawa, and Y. Shinohara Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling Cell Metab 16 2012 44 54
83. E.D. Javor, M.G. Ghany, E.K. Cochran, E.A. Oral, A.M. DePaoli, and A. Premkumar Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy Hepatology 41 2005 753 760
84. J.Y. Park, A.Y. Chong, E.K. Cochran, D.E. Kleiner, M.J. Haller, and D.A. Schatz Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy J Clin Endocrinol Metab 93 2008 26 31
85. F. Kamran, K.I. Rother, E. Cochran, E. Safar Zadeh, P. Gorden, and R.J. Brown Consequences of stopping and restarting leptin in an adolescent with lipodystrophy Horm Res Paediatr 78 2012 320 325
86. E. Safar Zadeh, A.O. Lungu, E.K. Cochran, R.J. Brown, M.G. Ghany, and T. Heller The liver diseases of lipodystrophy: the long-term effect of leptin treatment J Hepatol 59 2013 131 137
87. X. Liang, H. Pei, L. Ma, Y. Ran, J. Chen, and G. Wang Synthesis and biological evaluation of novel urea- and guanidine-based derivatives for the treatment of obesity-related hepatic steatosis Molecules 19 2014 6163 6183
88. B.L. Strom, M. Buyse, J. Hughes, and B.M. Knoppers Data sharing, year 1 - access to data from industry-sponsored clinical trials N Engl J Med 2014 10.1056/NEJMp1411794
89. C.C. Imes, and L.E. Burke The obesity epidemic: the United States as a cautionary tale for the rest of the world Curr Epidemiol Rep 1 2014 82 88
90. S. Daniel, T. Soleymani, and W.T. Garvey A complications-based clinical staging of obesity to guide treatment modality and intensity Curr Opin Endocrinol Diabetes Obes 20 2013 377 388
91. V.W. Barry, M. Baruth, M.W. Beets, J.L. Durstine, J. Liu, and S.N. Blair Fitness vs. fatness on all-cause mortality: a meta-analysis Prog Cardiovasc Dis 56 2014 382 390
92. C.L. Ogden, M.D. Carroll, B.K. Kit, and K.M. Flegal Prevalence of childhood and adult obesity in the United States, 2011-2012 JAMA 311 2014 806 814
93. J. Van de Voorde, B. Pauwels, C. Boydens, and K. Decaluwe Adipocytokines in relation to cardiovascular disease Metabolism 62 2013 1513 1521
94. S.A. Polyzos, and J. Kountouras Nonalcoholic fatty liver disease and adipokines: a novel role for fat imbalance Immuno-Gastroenterol 2 2014 129 131
95. T.A. Dardeno, S.H. Chou, H.S. Moon, J.P. Chamberland, C.G. Fiorenza, and C.S. Mantzoros Leptin in human physiology and therapeutics Front Neuroendocrinol 31 2010 377 393